The following formula illustrates how CMS would calculate the benchmark period manufacturer price for a Part D rebatable drug with a payment amount benchmark period identified under proposed 428.202(c)(1), as proposed in 428.202(d)(1): (AMP for calendar quarter beginning January 2021) multiplied by (sum of monthly AMP units for January 2021 calendar quarter divided by sum of the units reported for the 3 quarters of the payment amount benchmark period) + (AMP for calendar quarter beginning April 2021) multiplied by (sum of monthly AMP units for April 2021 calendar quarter divided by sum of the units reported for the 3 quarters of the payment amount benchmark period) + (AMP for calendar quarter beginning July 2021) multiplied by (sum of monthly AMP units for July 2021 calendar quarter divided by sum of the units reported for the 3 quarters of the payment amount benchmark period) For a Part D rebatable drug with a payment amount benchmark period identified under proposed 428.202(c)(2) through (5), the following formula illustrates how CMS would calculate the benchmark period manufacturer price for a Part D rebatable drug as proposed in 428.202(d)(2): (AMP for calendar quarter beginning January) multiplied by (sum of monthly AMP units for January calendar quarter divided by sum of the monthly units reported for the 4 quarters of the payment amount benchmark period) + (AMP for calendar quarter beginning April) multiplied by (sum of monthly AMP units for April calendar quarter divided by sum of the monthly units reported for the 4 quarters of the payment amount benchmark period) + (AMP for calendar quarter beginning July) multiplied by (sum of monthly AMP units for July calendar quarter divided by sum of the monthly units reported for the 4 quarters of the payment amount benchmark period) + (AMP for calendar quarter beginning October) multiplied by (sum of monthly AMP units for October calendar quarter divided by sum of the monthly units reported for the 4 quarters of the payment amount benchmark period) (4) Identification of the Benchmark Period CPI-U To calculate the inflation-adjusted payment amount in accordance with section 1860D-14B(b)(3), CMS must identify the benchmark period CPI-U

Iced fruit and frozen blends: Fruit shisha flavors mixed with mint or cooling notes, such as frozen blueberry, watermelon mint, frozen apple, and passion fruit blends
Oxygen helps fuel energy production and supports repair processes
As of July 22, 2020, the sale or barter, directly or indirectly, of any cigarettes, tobacco products, tobacco-related objects, alternative nicotine products, or vapor products to anyone under the age of 21 years is illegal in Georgia
The lower esophageal sphincter slowly regains strength as nicotine levels drop steadily in the system
In the CY 2024 PFS final rule, we established the Medicare Clinical Quality Measure for Accountable Care Organizations Participating in the Medicare Shared Savings Program (Medicare CQM) collection type in the APP quality measure set and finalized that the Medicare CQM collection type would be available to only ACOs participating in the Shared Savings Program